Navigation Links
Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics' Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial
Date:1/31/2011

DURHAM, N.C., Jan. 31, 2011 /PRNewswire/ -- Argos Therapeutics announced today that interleukin (IL)-12 secretion can predict the potency of the company's Arcelis™ dendritic cell (DC) immunotherapy and can be used as a potency marker in a Phase 3 clinical trial testing the company's lead product, AGS-003, in metastatic renal cell carcinoma (mRCC). In vitro results published in the Journal of Immunotherapy demonstrate that the potency of mature CD40L RNA electroporated DCs correlates with IL-12 secretion by tracking the multifunctional CD8(+)/CD28(+) memory T-cell responses.

"The dependence of AGS-003-induced memory cytotoxic T lymphocytes on IL-12 secretion from DCs makes it an attractive marker for DC potency," said Charles Nicolette, Ph.D., chief scientific officer and vice president of research and development of Argos. "Using IL-12 secretion as a potency marker is highly relevant to AGS-003 since it is directly linked to the mechanism of action and it is equally relevant to other Arcelis products such as AGS-004 for HIV."

Jeff Abbey, president and chief executive officer of Argos, added, "Identifying an effective potency marker for our upcoming Phase 3 clinical trial in mRCC is a significant step in the advancement of our pipeline. We are in the process of securing funding to begin the trial by mid-2011. Our Arcelis HIV program is currently being tested in a Phase 2b study co-funded by the NIH."

Electroporation of mature DCs with RNA-encoding CD40L greatly enhances the production of IL-12, a proinflammatory cytokine necessary for the induction of T-cell immunity. In vitro results presented in the Journal of Immunotherapy reveal a correlation between the priming of CD28(+) antigen-reactive effector memory CTL displaying three or four simultaneous effector functions and the quantity of IL-12 produced by post-maturation RNA electroporated DC. By using multiparameter flow cyt
'/>"/>

SOURCE Argos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Interleukin Genetics Reports Third Quarter 2010 Financial Results
2. Interleukin Genetics Moves Trading of Stock to OTCQB Marketplace
3. Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2010 Results
4. Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2010 Results
5. NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards
6. Interleukin Genetics to Raise $5.3 Million in Registered Direct Offering
7. Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis
8. Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Tests Impact on Weight Loss
9. Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis
10. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
11. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 Bayer HealthCare announced ... the Conquer Cancer Foundation of the American Society of ... health information technology platform designed to unlock vast quantities ... cancer.  "Bayer is proud to join ... to leverage Big Data to help people whose lives ...
(Date:3/5/2015)... 5, 2015   ndd Medical Technologies , a ... employs precise ultrasound technology, announced that its EasyOne Pro® ... the San Antonio Pulmonary Fibrosis Support Group. The clinic ... fibrosis (PF), as well as those suspected of having ... a mere 12 square inches, EasyOne Pro provides accurate ...
(Date:3/5/2015)... YORK , March 5, 2015  Relmada ... novel therapies for the treatment of chronic pain, ... and researchers to advisory roles. The panel of ... development programs and efforts to advance the company ... pain. They bring expertise in a range of ...
Breaking Medicine Technology:Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4
... , , MELBOURNE, Australia, Dec. 17 , Treatment ... points: , *Single injection of proprietary adult stem cells ... in blood glucose levels , *Stem cell treatment induced ... increase in insulin-producing beta cells , *Results indicate pancreas ...
... , SEATTLE, Dec. 17 Amnis Corporation, a manufacturer of ... present at the 28th Annual J.P. Morgan Healthcare Conference. The ... Francis Hotel in San Francisco. David Basiji, Ph.D., Amnis, ... 12 at 2:30 PM in Room F and will discuss ...
Cached Medicine Technology:Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes 2Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes 3
(Date:3/6/2015)... Further solidifying their position as a ... announced today that the company has earned Inavero’s Best ... of Staffing Talent Award five years in a row. ... Talent Diamond winners are proven industry leaders in service ... the individuals they have helped find temporary and permanent ...
(Date:3/6/2015)... Williamsport, PA (PRWEB) March 06, 2015 ... warning of a national shortfall of 90,000 doctors by ... media, Susquehanna Health (SH) is proactively preparing ... development, recruitment and patient access. , Several factors ... population, increasing number of insured under the Affordable Care ...
(Date:3/6/2015)... Since Medicare began paying for chronic care ... an overwhelming demand from providers for straightforward guidance on ... The Centers for Medicare & Medicaid Services (CMS) ... updated white paper—“ Providing and Billing Medicare for Chronic ... yet practical “how to” manual for providers looking to ...
(Date:3/6/2015)... March 06, 2015 Many patients with ... medical therapy. If you (or someone you know) have ... osteoarthritis, you may be interested in the ACT-OA clinical ... announced today that he is one of fifteen physicians ... to begin enrolling subjects as part of a new, ...
(Date:3/6/2015)... Washington, DC (PRWEB) March 06, 2015 ... the nation’s only comprehensive source for key trends and ... specialty spend, medical injectables. Executives from Magellan Rx Management ... Pharmacy Trend Report: Discover Your Hidden Specialty Drug Spend,” ... Atlantic Information Services, Inc. , Specialty drug spend makes ...
Breaking Medicine News(10 mins):Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... The ... dramas and advertisements. , ... Japan (PRWEB) December 22, 2009 -- Classico Inc. , the designer, manufacturer, and seller ... doctor coat rentals in order to provide doctor coats as costumes used in the filming ...
... , RIVERWOODS, Ill., Dec. 22 As both houses of ... Tax Briefings on the provisions of estate tax, tax extender and ... provider of tax, accounting and audit information, software and services ( CCHGroup.com ... , or: , for estate tax legislation, click here ; ...
... , SHENZHEN, China, Dec. 22 /PRNewswire-FirstCall/ - Hard ... announce that it has an agreement in principle to sell ... company in China. The buyer, founded in 2004, focuses on ... preparations. Name of the buyer will be announced in a ...
... finds slightly fewer behavioral issues among children whose moms ... -- The children of women who take low-dose aspirin ... delivering prematurely might have fewer behavioral problems at age ... aspirin to pregnant women who are apt to have ...
... music that contains references to marijuana are more likely to use ... according to a University of Pittsburgh School of Medicine study ... on an analysis of survey data from 959 ninth-graders, we found ... marijuana are almost twice as likely to have used the drug ...
... in Canada are reporting the development of a fast, ... that may exist in foods and beverages. Their paper-strip ... results in minutes rather than hours by means of ... published in ACS, Analytical Chemistry , a semi-monthly ...
Cached Medicine News:Health News:Classico Announces the Start of Free Stylish Lab Coat Rentals All Over the World 2Health News:Classico Announces the Start of Free Stylish Lab Coat Rentals All Over the World 3Health News:CCH Updates Briefings on Tax Provisions of Estate Tax, Tax Extender, Health Care Reform Bills 2Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 2Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 3Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 4Health News:Aspirin During Pregnancy May Help Preemies 2Health News:Aspirin During Pregnancy May Help Preemies 3Health News:Pot and pop: New research finds stronger link between music and marijuana use among teens 2
... The Ray TFC Unite Device is the anterior ... Ray TFC Unite device features the same 70% ... offered by fenestrations is paramount in the formation ... Ray TFC Unite system promotes load sharing between ...
... Ray Threaded Fusion Cage is a proven interbody* ... IDE). This device is a hollow threaded cylinder ... this contact the device promotes spinal fusion by ... Ray TFC is indicated for use with autogenous ...
... System has added a significant layer of ... It utilizes innovative technologies developed by Gen-Probe ... acid amplification technique called Transcription-Mediated Amplification (TMA).,The ... presence of HIV-1 and HCV in blood ...
... Test (Reveal Test) is MedMiras flagship rapid ... human serum or plasma against HIV-1 that ... to HIV infection. The Reveal Test is ... and is comprised of a single-use test ...
Medicine Products: